Search results for "Psychotic"

showing 10 items of 360 documents

IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.

2019

Aims: Cognitive impairment is a possible indicator of neurodevelopmental impairment, but not all psychotic patients are cognitively compromised. It has been suggested that heavy cannabis use may precipitate psychosis in those who show no such compromise. This study compares two samples of patients with first-episode psychosis and their respective non-psychotic controls, in London (UK) and Palermo (Italy), and examines whether different patterns of cannabis use are reflected in differences in IQ. Methods: The two studies used the same inclusion/exclusion criteria and instruments. The sample comprised 249 subjects from London (106 patients and 143 controls) and 247 subjects from Palermo (120 …

AdultCross-Cultural ComparisonMalePsychosismedicine.medical_specialtyAdolescentIntelligenceNeurodevelopmentYoung Adult03 medical and health sciences0302 clinical medicineCognitionFirst episode psychosisLondonmedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCognitive DysfunctionIn patientCannabiPsychiatryCognitive impairmentSettore MED/25 - PsichiatriaBiological PsychiatryMulticentric studybiologybusiness.industryConfoundingCognitionCannabis usemedicine.diseasebiology.organism_classification030227 psychiatryPsychiatry and Mental healthItalyPsychotic DisordersRisk factorsCase-Control StudiesFemaleMarijuana UseCannabisbusiness030217 neurology & neurosurgery
researchProduct

Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in s…

2007

The Screen for Cognitive Impairment in Psychiatry (SCIP) is a brief scale designed for detecting cognitive deficits in several psychotic and affective disorders. This study examined the psychometric properties of the Spanish version of the SCIP in a sample of outpatients suffering schizophrenia-spectrum disorders.Psychometric properties were evaluated in a sample of 126 stable patients with schizophrenia. Men and women 18 to 55 years of age were recruited from consecutive admissions to 40 psychiatric outpatient clinics in Spain and asked to complete a series of cognitive measures at baseline, as well as three versions of the SCIP separated by one week intervals. A matched sample of 39 healt…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyPsychometricsAdolescentPsychometricsConcurrent validityTest validityNeuropsychological TestsCronbach's alphaReference ValuesmedicineOutpatient clinicHumansMass ScreeningPsychiatryBiological PsychiatryMass screeningLanguageCognitive disorderNeuropsychologyReproducibility of ResultsMiddle Agedmedicine.diseasePsychiatry and Mental healthPsychotic DisordersSpainSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersClinical psychologySchizophrenia research
researchProduct

Functional outcome in bipolar disorder: the role of clinical and cognitive factors.

2007

Introduction:  Few studies have examined the clinical, neuropsychological and pharmacological factors involved in the functional outcome of bipolar disorder despite the gap between clinical and functional recovery. Methods:  A sample of 77 euthymic bipolar patients were included in the study. Using an a priori definition of low versus good functional outcome, based on the psychosocial items of the Global Assessment of Functioning (GAF, DSM-IV), and taking also into account their occupational adaptation, the patients were divided into two groups: good or low occupational functioning. Patients with high (n = 46) and low (n = 31) functioning were compared on several clinical, neuropsychologica…

AdultEmploymentMalemedicine.medical_specialtyBipolar DisorderGlobal Assessment of FunctioningNeuropsychological TestsSeverity of Illness IndexAdaptation PsychologicalmedicineHumansPsychologyBipolar disorderEffects of sleep deprivation on cognitive performancePsychiatryBiological PsychiatryDemographyNeuropsychologyCognitionmedicine.diseaseExecutive functionsAntidepressive AgentsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthFemaleVerbal memoryPsychologyCognition DisordersPsychosocialSocial AdjustmentClinical psychologyAntipsychotic AgentsBipolar disorders
researchProduct

Intra- and Interhemispheric Electroencephalogram Coherence in Siblings Discordant for Schizophrenia and Healthy Volunteers

1997

Former studies had pointed to an increased electroencephalogram (EEG) coherence in schizophrenics, but it remained unsolved whether this deviation represents the premorbid state or is only a consequence of the current or previous schizophrenic episodes. To clarify this question, we tested the hypothesis that subjects at elevated risk also reveal higher coherences compared to healthy controls. For that, intra- and interhemispheric EEG coherences were investigated in untreated schizophrenics, their healthy siblings, and healthy controls. Differences were only found regarding the intrahemispheric coherences. Both in schizophrenics and, even though to a lesser degree, in their siblings signific…

AdultGenetic MarkersMalePsychosismedicine.medical_specialtyAudiologyElectroencephalographyReference ValuesRisk FactorsMaldevelopmentHealthy volunteersmedicineHumansAttentionSiblingDominance CerebralPsychiatryBiological PsychiatryCerebral CortexFourier Analysismedicine.diagnostic_testElectroencephalographySignal Processing Computer-AssistedCoherence (statistics)medicine.diseasePsychotic DisordersSchizophreniaCerebral hemisphereSchizophreniaFemaleArousalPsychologyBiological Psychiatry
researchProduct

Non-adherence to psychotropic medication assessed by plasma level in newly admitted psychiatric patients: Prevalence before acute admission.

2019

Aims Non-adherence or partial adherence to psychotropic medication is found in 18-70% of patients. Many previously used methods for the assessment of adherence (e.g. questionnaires, pill counts, and electronic systems), however, might underreport actual rates of non-adherence to medication. The aim of this study was to quantify adherence using plasma level. Methods We conducted a 6-week prospective study of all consecutive admitted patients at the Paracelsus Medical University of Salzburg, Clinics of Psychiatry and Psychotherapy, who had been treated with antipsychotics/antidepressants prior to admission (pre-medication dosage in 161 of 233). Plasma drug levels were determined and compared …

AdultHospitals PsychiatricMalemedicine.medical_specialtymedicine.medical_treatmentMedication Adherence03 medical and health sciences0302 clinical medicinePharmacotherapyPatient AdmissionPrevalenceMedicineHumansDosingProspective StudiesAntipsychoticProspective cohort studyPsychiatrymedicine.diagnostic_testbusiness.industryMood DisordersGeneral NeuroscienceMental DisordersGeneral MedicineMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthNeurologyTherapeutic drug monitoringSchizophreniaPillSchizophreniaAntidepressantFemaleNeurology (clinical)business030217 neurology & neurosurgeryAntipsychotic AgentsPsychiatry and clinical neurosciences
researchProduct

The role of resources in the face of psychopathology

2019

OBJECTIVES The current study compared resource realization and psychological distress in patients with different psychiatric diagnoses and healthy individuals and examined the moderating effect of intrapersonal resources (personal strengths) and interpersonal resources (relationships) on the association between incongruence (unsatisfactory realization of personal goals) and psychological distress. METHOD In total, 218 participants (45.87% female, mean age = 39.83 years) completed standardized questionnaires at one measurement point. RESULTS Healthy individuals (n = 56) reported the most resources, followed by patients with psychotic (n = 53), substance use (n = 53), and depressive disorders…

AdultMale050103 clinical psychologySubstance-Related DisordersInterpersonal communicationPsychological Distress03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Surveys and QuestionnairesmedicineHumansInterpersonal Relations0501 psychology and cognitive sciencesAssociation (psychology)Depression (differential diagnoses)Depressive DisorderPsychopathology05 social sciencesPsychological distressMiddle AgedResilience Psychologicalmedicine.diseaseHealthy Volunteers030227 psychiatryPsychotherapySubstance abuseClinical PsychologyPsychotic DisordersFemaleSubstance usePsychologyIntrapersonal communicationClinical psychologyPsychopathologyJournal of Clinical Psychology
researchProduct

Smoking does not impact social and non-social cognition in patients with first episode psychosis.

2018

Abstract Background Many studies having shown significant improvements in non-social and social cognitive performance in smoking FEP patients compared to non-smoking FEP patients. The findings are controversial. This study analyzed the effects of tobacco use on non-social and social cognitive function in a large group of FEP patients and a matched healthy control group. Methods A sample of 335 patients with FEP and 253 healthy controls was divided into four subgroups: control tobacco users (CTU), control non-tobacco users (CNTU), patient tobacco users (PTU) and patient non-tobacco users (PNTU). Demographic variables, tobacco use variables (presence or absence, frequency and duration of toba…

AdultMaleAdolescent03 medical and health sciencesExecutive FunctionYoung Adult0302 clinical medicineCognitionSocial cognitionFirst episode psychosismedicineTobacco SmokingHumansLongitudinal StudiesProspective StudiesChildSocial BehaviorBiological PsychiatryWorking memorybusiness.industryCognitionTobacco Use DisorderExecutive functionsmedicine.disease030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesMemory Short-TermPsychotic DisordersSchizophreniaFemalebusinessNeurocognitive030217 neurology & neurosurgerySocial cognitive theoryClinical psychologySchizophrenia research
researchProduct

Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors

1998

Pharmacokinetic interactions of clozapine and its metabolites N-desmethylclozapine and clozapine N-oxide with the selective serotonin reuptake inhibitors (SSRIs) fluvoxamine and paroxetine were investigated in a prospective study in schizophrenic patients under steady-state conditions. Thirty patients were treated with clozapine at a target dose of 2.5 to 3.0 mg/kg of body weight. After gradual dose escalation, serum concentrations of clozapine and two metabolites were determined twice at 7-day intervals after steady-state conditions had been reached. Then, fluvoxamine (50 mg/day) or paroxetine (20 mg/day) was added in 16 and 14 patients, respectively. Serum concentrations of clozapine and …

AdultMaleAdolescentFluvoxaminePharmacologyPharmacokineticsmedicineHumansDrug InteractionsPharmacology (medical)Prospective StudiesProspective cohort studyClozapineClozapinebusiness.industrySmokingMiddle AgedDrug interactionParoxetineParoxetinePsychiatry and Mental healthFluvoxamineSchizophreniaFemaleSerotoninbusinessReuptake inhibitorSelective Serotonin Reuptake InhibitorsAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Addition of Low-Dose Fluvoxamine to Low-Dose Clozapine Monotherapy in Schizophrenia: Drug Monitoring and Tolerability Data from a Prospective Clinica…

1999

Combining fluvoxamine and clozapine may be a strategy to improve therapeutic effects on negative symptoms in schizophrenic patients. Fluvoxamine, however, markedly inhibits the metabolism of clozapine, and hazardous side effects may result. This study prospectively investigated the safety and tolerability of an add-on therapy with fluvoxamine to a clozapine monotherapy in schizophrenic patients. Sixteen schizophrenic patients received 50 mg fluvoxamine as a comedication after having reached steady-state conditions under clozapine monotherapy. Patients were monitored for subjective adverse events, laboratory parameters, EEG and ECG recordings, orthostatic hypotension and their psychopatholog…

AdultMaleAdolescentMatched-Pair AnalysisFluvoxamineDrug Administration ScheduleOrthostatic vital signsmedicineHumansDrug InteractionsPharmacology (medical)Prospective StudiesAdverse effectClozapineClozapineTherapeutic effectGeneral MedicineMiddle AgedDrug interactionPsychiatry and Mental healthTreatment OutcomeTolerabilityFluvoxamineAnesthesiaSchizophreniaAntidepressive Agents Second-GenerationDrug Therapy CombinationFemaleDrug MonitoringPsychologyReuptake inhibitorSelective Serotonin Reuptake InhibitorsAntipsychotic Agentsmedicine.drugPharmacopsychiatry
researchProduct

Impaired Right Temporoparietal Junction–Hippocampus Connectivity in Schizophrenia and Its Relevance for Generating Representations of Other Minds

2018

Schizophrenia is associated with impaired and exaggerated Theory of Mind processes, pointing on alterations in generating a representation of another person's mind. Despite recent work on healthy subjects suggesting that a coupling between the right temporoparietal junction (rTPJ) and the hippocampus is relevant for building representations of others' intentions, the neural basis of related dysfunctions in patients with schizophrenia remains unclear. Therefore, we used structural and functional magnetic resonance imaging together with a modified prisoner's dilemma game to test the hypotheses, that patients show dysfunctional social updating on behavioral level accompanied by altered rTPJ-hi…

AdultMaleAdolescentMiddle temporal gyrusTemporoparietal junctionTheory of MindHippocampusYoung Adult03 medical and health sciences0302 clinical medicineSocial cognitionParietal LobeTheory of mindConnectomemedicineHumansSocial BehaviorFusiform gyrusmedicine.diagnostic_testMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTemporal Lobe030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structurePsychotic DisordersSocial PerceptionMentalizationSchizophreniaSchizophreniaFemalePsychologyFunctional magnetic resonance imaging030217 neurology & neurosurgeryRegular ArticlesCognitive psychologySchizophrenia Bulletin
researchProduct